People with type 2 diabetes using tirzepatide alongside other diabetes medications face hypoglycemia risks that those using it for weight loss alone do not
Monthly Cost Breakdown: Annual Cost Comparison: For Cash-Pay Patients (No Insurance Coverage): Savings Scenarios: Scenario 1: Currently Paying Full Price for Mounjaro Situation: No insurance or insurance doesnt cover Paying $1,069/month for Mounjaro Need medication for 18 months to reach goal weight Current Cost: 18 months $1,069 = $19,242 Switching to Compounded Tirzepatide: 18 months $349 = $6,282 Total Savings: $12,960 Switching to Compounded Semaglutide: 18 months $199 = $3,582 Total Savings: $15,660 Scenario 2: High Insurance Copays Situation: Insurance covers Mounjaro but with $250/month copay Deductible of $3,000 not yet met First 3 months paying full price, then copays Current Cost: 3 months $1,069 (deductible) = $3,207 15 months $250 (copay) = $3,750 Total 18 months: $6,957 Switching to Compounded Tirzepatide: 18 months $349 = $6,282 Total Savings: $675 Plus no insurance hassles, prior authorizations, or coverage uncertainty Scenario 3: No Access to Mounjaro Situation: Mounjaro out of stock at all local pharmacies Been waiting 2 months for availability Weight loss journey stalled Current Cost: Zero progress toward health goals Continued health risks from obesity Frustration and lost momentum Switching to Compounded Tirzepatide: Immediate access within 3-7 days Resume weight loss progress $349/month for treatment vs
This can happen because tirzepatide often causes nausea, vomiting, or diarrhea in some people, especially when the dose is first increased
Reduced appetite suppression, unexpected side effects, or injection site reactions that differ from your normal experience could indicate that the medication has degraded
Diarrhea Diarrhea affects about 29.7% of semaglutide 2.4 mg users in the STEP trials versus 15.9% on placebo
